B:EXPECT

Si-Yuan Chen1, Peng-Peng Xu1, Ru Feng2

  • 1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.

概括

扩散性大B细胞淋巴瘤 (DLBCL) 与外节参与 (ENI) 的预后不好,特别是多个部位. 基因亚型引导免疫化学疗法在治疗外节性DLBCL方面显示出有希望的疗效.